Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L) LSE

60.70

+0.55(+0.91%)

Updated at December 05 11:07AM

Currency In EUR

Valuation

Market Cap3.21B
Enterprise Value3.31B
P/E Ratio23.3
PEG Ratio-7.19
Price/Sales Ratio4.11
Price/Book Ratio5.47
Enterprise/Revenue4.23
Enterprise/EBITDA15.55

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.18
Operating Margin0.23

Management Effectiveness

Return On Assets0.15
Return On Equity0.23

Income Statement

Revenue763.75M
Revenue/Share14.64
Gross Profit449.68M
EBITDA208.2M
Net Income136.88M
Diluted EPS2.68

Balance Sheet

Total Cash47.62M
Total Cash/Share0.93
Total Debt129.3M
Total Debt/Equity0.23
Current Ratio2.77
Book Value Per Share11.24

Price History

52-Week Change-5.65
52-Week High79.76
52-Week Low37.14
Moving Average 50 Days67.54
Moving Average 200 Days53.85

Statistics

Average Volume11,270
Shares Outstanding51.15M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.94
Trailing Annual Dividend Yield1.55
Payout Ratio0.43
Last Split FactorN/A
Last Split DateN/A